Molecule intelOpportunity: Strong0

Iodide

12 brands · 12 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
51
Market saturation
30
Price room
100
Regulatory risk
50
12
brands
12
companies
Rs 46.02
median price
14
price points
5.16x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 30.5
MedianRs 46.02
Most expensiveRs 157.25
Spread5.16×
Sources: DRAP-official

max/min price ratio 5.16x across 14 trusted points (Rs 30.5-157.25). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Iodide — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2026-03-11
17. Volunatry Recall. Osilex-D (Glitz Pharma)

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(70) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

12 canonical companies and 12 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 5.16x across 14 trusted points (Rs 30.5-157.25). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-03-11 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.